NDC 72934-8171

SALICYLIC ACID 2% / SODIUM SULFACETAMIDE MONOHYDRATE 8%

Salicylic Acid 2% / Sodium Sulfacetamide Monohydrate 8%

SALICYLIC ACID 2% / SODIUM SULFACETAMIDE MONOHYDRATE 8% is a Topical Suspension in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Sulfacetamide Sodium; Salicylic Acid.

Product ID72934-8171_89067701-e5b3-1c3d-e053-2a95a90a4e11
NDC72934-8171
Product TypeHuman Prescription Drug
Proprietary NameSALICYLIC ACID 2% / SODIUM SULFACETAMIDE MONOHYDRATE 8%
Generic NameSalicylic Acid 2% / Sodium Sulfacetamide Monohydrate 8%
Dosage FormSuspension
Route of AdministrationTOPICAL
Marketing Start Date2019-05-17
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameSULFACETAMIDE SODIUM; SALICYLIC ACID
Active Ingredient Strength8 g/100g; g/100g
Pharm ClassesSulfonamide Antibacterial [EPC],Sulfonamides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-8171-6

120 g in 1 CYLINDER (72934-8171-6)
Marketing Start Date2019-05-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-8171-6 [72934817106]

SALICYLIC ACID 2% / SODIUM SULFACETAMIDE MONOHYDRATE 8% SUSPENSION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-17

Drug Details

Active Ingredients

IngredientStrength
SULFACETAMIDE SODIUM8 g/100g

OpenFDA Data

SPL SET ID:89067701-e5b2-1c3d-e053-2a95a90a4e11
Manufacturer
UNII

Pharmacological Class

  • Sulfonamide Antibacterial [EPC]
  • Sulfonamides [CS]
  • Sulfonamide Antibacterial [EPC]
  • Sulfonamides [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.